Hemosure is a sandwich dye conjugate immunoassay to selectively identify human hemoglobin in test samples with a high degree of sensitivity and specificity. (FDA 510K#: K808012) Each patient screening kit includes 1 dispensing envelope, 3 collection cards, 3 applicator sticks, and 1 pouch.Hemoccult and Hemoccult II are registered trademarks of Beckman Coulter, Inc. SENSA is a registered trademark of SmithKline Diagnostics, Inc.Hemoccult ICT has been proven to be one of the highest and most clinical advanced immunochemical tests with high sensitivity and specificity. Hemoccult ICT has been proven to be one of the highest and most clinical advanced immunochemical tests with high sensitivity and specificity. Our robust marketplace offers lab & medical supplies, drug testing devices, analyzers, and much more!Most orders placed before 8 PM Eastern Time process the same day!For the best experience on our site, be sure to turn on Javascript in your browser.To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies.
In addition to the inherent specificity and sensitivity, Hemosure® test can be performed by health care providers in hospitals, labs and private practices. Because of its superior specificity for lower GI bleeding, Hemoccult ICT is an ideal screening tool for colorectal cancer (CRC), and this specificity also reduces the number of false positive test results. Safe and non invasive, Hemoccult ICT is very patient friendly, as there are no diet or drug restrictions for patients to follow while they are using it, which helps increase patient compliance. Results FDA CLIA Database The initial FIT listed in the CLIA database was the Immunochemical tests are part of the standard of care and screening program for colorectal cancer screening programs worldwide. Another benefit of Hemosure’s test is that it provides greater than 97 Sensitivity: The sensitivity of the test is 50ng hHb/mL buffer or 50µg hHb/g feces. 14, 16, 17 Compared to other studies, our results showed that with the three‐sample setting, the CFOBT test has lower specificity in the colonoscopic normal group (75.5%), but had a similar level of sensitivity. In addition, manufacturing of PPE and many other wound care and infection prevention products have been impacted by global response to coronavirus. Hemosure One-Step Fecal Occult Blood Test. ity and specificity for synthetic fecal samples and the over-all sensitivity and specificity for each FIT device across testing programs, along with 95% Agresti-Coull binomial proportion confidence intervals were calculated,48 using SAS version 9.4 (SAS, Inc, Cary, NC). It detects as low as 50 ng HB/ml and is human hemoglobin specific. Test Specifi city Sensitivity Accuracy Number of Samples Manufacturer Hemoccult ICT 99.1% 100% 1 to 3 samples Beckman Coulter InSure FIT 98% 87% 2 Samples Enterix OC-Light FIT 100% 98% 1 Sample Polymedco Accutest iFOBT 96.7% 99.2% 98.3% 1 or 2 samples Jant Pharma-ceutical Corp. Hemosure iFOBT 96% 87% >97% 1 sample Hemosure Inc. Sensitivity: The sensitivity of the test is 50ng hHb/mL buffer or 50µg hHb/g feces. ... some had low sensitivity and specificity and probably should not be used for population-based or other screening. Because of its superior specificity for lower GI bleeding, Hemoccult …
1. Hemoglobin from horse, pigs, fish, beef, chicken, rabbit, rat, goat, and mouse do not react with Hemosure® One Step Immunological Fecal Occult Blood Test. Hemosure is a sandwich dye conjugate immunoassay to selectively identify human hemoglobin in test samples with a high degree of sensitivity and specificity. Regarding sensitivity, Hemosure’s tests has greater than 87 percent sensitivity.
No need to send fecal samples to the laboratory. Doctors can easily, quickly and accurately read the test results in 5 to 10 minutes. This test is CLIA Waived and FDA-Cleared. Specificity: Hemosure® One Step Immunological Fecal Occult Blood Test is specific for human hemoglobin. Forgot Username or Password?
2.
Clinical sensitivity and specificity Fecal immunochemical testing (FIT) can identify as little as 0.3 ml of daily blood in the stool; yet this test threshold doesn't cause undue false positives from normal upper intestinal blood leakage because it does not detect occult … Sensitivity: 50ng hHB/mL; Specificity: over 96%; Useful aid in the diagnosis and therapy of gastrointestinal disorders; Patient-friendly for use in physicians' offices, labs, hospitals, clinics, or homes No need to send fecal samples to the laboratory. 2. It only has a sensitivity of 48 percent for detecting colorectal cancer per the USPFT guidelines and even lower for advanced adenomas. Please select your market so that we can provide you customized content:Due to the coronavirus outbreak worldwide, global demand for some personal protective equipment (PPE) is exceeding supply. This new technology has greatly improved specificity, sensitivity, accuracy and cost-effectiveness of the fecal occult blood tests. Hemoccult ICT is the latest and most advanced fecal occult blood test (FOBT) in the Hemoccult product line. Hemosure ® one-step iFOB Test (FIT). The SEPT9 DNA test has lower sensitivity and specificity than the other tests. In addition, its specificity is 16 points lower than the FIT test and at a higher cost. For IFOBT, the sensitivity is in the range of 80–87% and the specificity ranges from 87 to 97%. Login We will price match guarantee on this item! Specificity: Hemosure® One Step Immunological Fecal Occult Blood Test is specific for human hemoglobin.